tiprankstipranks
Esperion reinstated with a Neutral at Goldman Sachs
PremiumThe FlyEsperion reinstated with a Neutral at Goldman Sachs
2M ago
Esperion initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Esperion initiated with an Overweight at Cantor Fitzgerald
2M ago
Esperion entered into licensing agreement with Neopharm Israel
Premium
The Fly
Esperion entered into licensing agreement with Neopharm Israel
2M ago
Esperion announces Otsuka submitted NDA to Japanese MHLW for bempedoic acid
PremiumThe FlyEsperion announces Otsuka submitted NDA to Japanese MHLW for bempedoic acid
3M ago
Esperion highlights exploratory data from CLEAR outcomes trial of Nexletol
Premium
The Fly
Esperion highlights exploratory data from CLEAR outcomes trial of Nexletol
3M ago
Esperion Therapeutics Sees Significant Revenue Growth in Q3 2024
Premium
Company Announcements
Esperion Therapeutics Sees Significant Revenue Growth in Q3 2024
4M ago
Esperion management to meet with Jefferies
PremiumThe FlyEsperion management to meet with Jefferies
6M ago
Options Volatility and Implied Earnings Moves Today, August 12, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 12, 2024
6M ago
Esperion reaffirms FY24 revenue view $225M-$245M, consensus $322.41M
Premium
The Fly
Esperion reaffirms FY24 revenue view $225M-$245M, consensus $322.41M
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100